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Objectives: The purpose of this study was to examine the uptake and predictors of monovalent human 
rotavirus and pneumococcal conjugate vaccines in Malawi. 
 
Methods: This study utilized cross-sectionl data obtained from the 2015-16 Malawi Demographic and 
Health Survey. The vaccination uptake was defined as children aged 12-35 months who received all 
two doses for rotavirus vaccines and all three doses for pneumococcal vaccines before first birthday. 
Multivariate logistic regression was used to identify the factors related to uptake of pneumococcal and 
rotavirus vaccination. 
 
Results: The uptake of rotavirus vaccine was 90.96% whilst of pneumococcal vaccine was 88.84%. 
The multivariate results show that children born to women with no formal education, who did not have 
postnatal care for the baby within two weeks, had no vaccination card/had vaccination card but its 
whereabouts was not known were less likely to achieve vaccination uptake. Furthermore, children from 
northern region had increased odds of achieving vaccination uptake. 
 
Conclusions: Strategies aimed at increasing further uptake of rotavirus and pneumococcal vaccines in 






























Globally diarrhea and pneumonia are two major leading cause of morbidity and mortality 
among young children [1][2]. Most diarrheal disease in children are attributed to rotaviruses which 
cause gastroenteritis, an inflammation of the stomach and intestines that can lead to severe dehydration, 
hospitalization, and even death in young children [3][4]. On the other hand, diseases caused by 
Streptococcus pneumoniae constitute also a major global public health problem in children [5][6]. In 
2010, it was estimated that there were about 1.73 billion episodes of diarrhea and 120 million episodes 
of pneumonia in children younger than 5 years. It was further estimated that 700 000 episodes of 
diarrhea and 1.3 million of pneumonia progressed to death [2]. 
In Malawi, approximately 11% of mortality in young children are caused by diarrhea [7][8]. 
Specifically, more than 2,500 deaths are attributed to Rotavirus accounting for 4.5 percent of all under 
five mortality. Moreover, it was reported that rotavirus causes an estimated one-third of diarrheal 
disease related hospitalizations [7][9]. In sub Saharan, pneumonia was reported to cause 935,000 deaths 
in young children and in Malawi 6903 of hospital death in preschool age children were attributed to 
severe pneumonia [10]. The pneumococcal vaccine protects against Streptococcus pneumoniae 
bacteria, which cause severe pneumonia, meningitis, otitis media and other illnesses [4][11]. On the 
other hand, the WHO ingeminates that rotavirus vaccines are an important measure that can be used to 
reduce severe rotavirus-associated diarrhea and child mortality [12]. Thus, the use of rotavirus and 
pneumococcal vaccines should be part of a comprehensive strategy to control diarrhea and pneumonia 
diseases among young children. 
The Government of Malawi introduced the pneumococcal conjugate vaccine (PCV13) and 
monovalent human rotavirus vaccine (RV1) into the nation’s infant immunization programme in 
November 2011 and October 2012 [13]. Studies in Malawi show that rotavirus vaccines are safe and 
effective against severe rotavirus disease and are a cost-effective intervention [14][15]. Despite that 
previous studies have explored predictors of uptake and timeliness of newly introduced rotavirus and 
pneumococcal vaccines in Malawi [16], these studies did not use nationally representative samples. 
Thus the aim of this study was to investigate the uptake and predictors of rotavirus and pneumococcal 
vaccines in Malawi.   
 
MATERIAL AND METHODS 
Data, sampling, and design 
This paper used publicly available data obtained from the 2015-16 Malawi Demographic and 
Health Survey (MDHS) which were collected from October 2015 to February 2016. Methods used in 
this study has been described in details elsewhere [4]. Briefly, the 2015-16 MDHS utilized a stratified 
two-staged cluster sampling design and produced a nationally representative sample. In the first stage, 
850 standard enumeration areas (SEAs) were randomly selected with probability proportional to the 
size. The second stage selected a sample of households with an equal probability systematic selection.  
Data collection 
The MDHS collected information from women of reproductive age (15–49 years) who had 
children below the age of 5 years prior to the survey by means of face to face interviews. In the 
interviewed households, 24,562 of the 25,146 eligible women were interviewed representing a 98% 
response rate. The main purpose of the MDHS is to provide the much needed data on the measures of 
population health, sociodemographic, environmental, anthropometry, HIV/AIDS, and child health 
indicators. Information on the monovalent human rotavirus vaccine (RV1) and pneumococcal 
conjugate vaccine (PCV13) were obtained in two ways. Mothers were asked to show whether they had 
a vaccination card for each child born 5 years prior to the data collection. If the mother could not show 
an immunization card, she was then asked to report whether the child had received any vaccination. 
Mothers were asked; Has (NAME) ever received a rotavirus vaccination, that is, liquid in the mouth to 
prevent diarrhea? How many times did (NAME) receive the rotavirus vaccine? Furthermore, mothers 
were asked, has (NAME) ever received a pneumococcal vaccination (PCV), that is, an injection in the 




The dependent variables of this study were monovalent human rotavirus vaccine (RV1) and 
pneumococcal conjugate vaccine (PCV13). Uptake was defined as children aged 12-35 months who 
had received all two doses of the monovalent human rotavirus vaccine (RV1) and all three doses of the 
pneumococcal conjugate vaccine (PCV13) before their first birthday. To ensure that children who were 
born after October 2012, received all recommended vaccines, an age range 12–35 months was chosen. 
Furthermore, by means of a simple random procedure, one child per mother was sampled so as to avoid 
the clustering effects generated from children who resided in same households. Figure 1. Shows a flow 
chart of the sample inclusion and exclusion criteria. 
Independent variables 
Child-specific factors included child’s sex (male/female), the birth order (1/2/3/4–5/and ≥ 6) 
and place of delivery (home and other/hospital/institution). Maternal and household characteristics 
included age in years (15–24/25–34/35–49), educational attainment (no formal 
education/primary/secondary education and above), employment status (no formal employment/ white 
collar/and blue collar), household wealth status (poorest/poorer/middle/richer/ and richest), perceived 
distance to health facility (no big problem/big problem). The number of under-5-year children in the 
household (≤1/ 2–3/and ≥ 4), the number of antenatal care visits (no visits/ inadequate visits/and 
adequate visits), vaccination card (no card or no longer has card/ has card but not seen/and has card and 
seen), place of residence (urban/rural), and geographical region (northern/central/and southern). The 
household wealth index is a composite measure of a household’s cumulative living standard and was 
calculated using easy-to-collect data on a household’s ownership of selected assets, such as televisions 
and bicycles. Household asset scores were generated through a principal component analysis by the 
measure DHS. The resulting asset scores were standardized and categorized into quintiles [17]. 
Data analysis 
All data analyses were performed using statistical analysis software (SAS) for Windows, 
version 9.4 (SAS Institute, Cary, NC, USA) [18][13]. Baseline sociodemographic characteristics were 
presented as frequencies and percentages. By means of the Chi-Square test of independence, the 
bivariate analyses were performed to determine the association between sociodemographic 
characteristics and uptake of the pneumococcal conjugate vaccine (PCV13) and monovalent human 
rotavirus vaccine (RV1). The variables that showed significance at p ≤ 0.25 on Chi-Square were 
retained for regression models. The multivariate analyses were conducted using a series logistic models 
(e.g., children, maternal/households, health care utilization, and community characteristics) to estimate 
the effects of the sociodemographic predictors on the uptake of the pneumococcal conjugate vaccine 
(PCV13) and monovalent human rotavirus vaccine (RV1). The survey-specific SAS procedures for 
weighting, clustering, and stratification in the survey design (PROC SURVEYSELECT, PROC 
SURVEYFREQ and PROC SURVEYLOGISTIC) were conducted. Regression analyses were 
performed separately for each dependent variables. In each model, unadjusted and adjusted odds ratios 
(aORs) and 95% confidence intervals (CIs) with their p values were calculated. Statistical significance 
was defined as p value < 0.05. 
Ethical considerations 
The protocols of the MDHS 2015-16 were reviewed and approved by the Malawi National 
Health Sciences Research Committee (NHSRC) and the Institutional Review Board (IRB) of ICF 
Macro. All participants gave written and informed consent before each interview. The authors were 
granted permission by the DHS program for the use of the data. 
RESULTS 
Basic characteristics of the study sample 
In total, 4938 children ageing between 12 to 35 months were analyzed in this study. The uptake 
of pneumococcal conjugate vaccine (PCV13) and monovalent human rotavirus vaccine (RV1) were 
estimated at 88.84% and 90.96% respectively. Table 1 show the baseline characteristics of the study 
sample. In terms of child characteristics, about 51% of children were female and a majority of children 
were in the 2–3 birth order. As regards household factors, approximately one-third of respondents were 
distributed in the age group 20 to 24 years, two-thirds of respondents had primary school education and 
a majority (60%) had blue collar job. Furthermore, about two-thirds (63%) households had at most one 
under-five year old child and nearly half (47%) of the households were not exposed to any form of 
media. In terms of health service utilization, a majority (94%) of births occurred in health faculties, 
91% had tetanus toxoid injection during pregnancy. Similarly, 92% of respondents had skilled 
attendance during delivery. Nearly 60% of respondents had big problems with distance to the nearest 
health facility, and approximately 70% of respondents started their antenatal check in the second 
trimester. In addition, 74%, 53% and 45% of respondents had vaccination card and seen, adequate 
ANC visits and PNC check for the baby within two months respectively. In terms of community 
characteristics, a majority of respondents were rural (86%) and southern region (46%) dwellers.  
Factors associated with rotavirus vaccine  
Table 3 shows results of multivariate logistic regression results of monovalent human rotavirus 
vaccine (RV1). Achieving uptake was significantly lower among children whose mothers had no 
formal education (aOR: 0.40; 95% CI: 0.24–0.66) compared children whose mothers had secondary 
and post-secondary education. Achieving rotavirus vaccination uptake was also significantly lower 
among children whose mothers had no PNC check for the baby check within 2 months (aOR: 0.68; 
95% CI: 0.49–0.92) compared to children born from mothers who had PNC check for the baby check 
within 2 months. Furthermore, achieving complete immunization was much lower among children who 
had no vaccination card/no longer had a card (aOR: 0.26; 95% CI: 0.49–0.92) and who had a card but 
its whereabouts was not known (aOR: 0.33; 95% CI: 0.22–0.39) compared to children who had 
vaccination card and its whereabouts was known. 
 
Factors associated with pneumococcal conjugate vaccine  
Table 3 also shows results of multivariate logistic regression results of pneumococcal conjugate 
vaccine, compared to children whose mothers had secondary school and post-secondary school 
education, achieving uptake (aOR: 0.52; 95% CI: 0.33–0.85) was significantly lower among children 
whose mothers had no formal education. Achieving pneumococcal conjugate vaccine uptake was also 
significantly lower among children whose mothers had no PNC check for the baby check within 2 
months (aOR: 0.65; 95% CI: 0.49–0.86) compared to children born from mothers who had PNC check 
for the baby check within 2 months. Furthermore, achieving complete immunization was much lower 
among children who had no vaccination card/no longer had a card (aOR: 0.12; 95% CI: 0.09–0.15) and 
who had a card but its whereabouts was not known (aOR: 0.09; 95% CI: 0.06–0.13) compared to 
children who had vaccination card and its whereabouts was known. However, compared to children 
from southern region, the odds of achieving pneumococcal vaccination uptake was significantly higher 
among children from northern region (aOR: 1.82; 95% CI: 1.19–2.80).  
DISCUSSION 
This is the first study that has shown the predictors of childhood rotavirus and pneumococcal 
uptake in Malawi using a national representative sample. The study has demonstrated that uptake of 
these two vaccines was high, however, the coverage of pneumococcal vaccine is falling short the 
benchmark set by the WHO [19]. In the multivariate analysis, maternal education, PNC check for the 
baby within two months, vaccination card, and geographical region were significantly associated with 
uptake of these two vaccines among the children aged 12–35 months in Malawi.  
The current study revealed that lack of PNC follow up was strongly linked with defaulting from 
achieving uptake of rotavirus and pneumococcal vaccination. Along with prior studies conducted in 
Ethiopia and Kenya with similar results [20][21][22][23], this may suggests that mothers who did not 
have PNC follow up are not getting sufficient information about the child vaccination schedule. In 
addition, women who have frequent ANC visits and PNC follow up might be more satisfied with the 
health care system and become aware of the need for vaccination which in turn may make them more 
likely to return for child vaccination [24][25]. 
In line with previous studies on vaccination coverage in general, the current study found that 
children who had vaccination card had increased odds of receiving complete sets of rotavirus and 
pneumococcal vaccines [26][27]. Prior research has demonstrated that being in possession of a child’s 
immunization card allows the mother to easily follow the immunization schedule and as such they may 
be in apposition to return at health facilities in time to have their babies immunized. Moreover, it has 
been reported that having an immunization card which is well-kept and clearly-labeled can prevent 
mothers from missing out on vaccinations schedules [26]. On the other hand, mothers who do not have 
immunization cards might avoid seeking immunization services for fear of ill-treatment from some 
health care providers as a result of misplaced, lost or spoiled child health card [28].  
As with previous studies [16][26][29][30], children born from mothers who had no formal 
education were less likely to achieve uptake of these two vaccines. Prior studies reported that maternal 
education influence women’s autonomy, changes in traditional beliefs, and women’s control over 
household resources [31][22]. Thus, women’s healthcare-seeking behavior and as well as ability to 
understand health knowledge may be enhanced more quickly either through social circumstances or 
cognitive priming that education affords [26][29].   
Children from the northern region were more likely to achieve the uptake of pneumococcal 
vaccination compared to those from the southern region. In this context, vaccination may reveal intra-
regional and intra-ethnic differences because of economic, political, and climatic factors and diverse 
sociocultural norms that might affect childcare practices [32]. In Malawi, the northern region has the 
most favorable health characteristics (e.g., a large percentage of men and women had completed 
primary and secondary education, exposure to mass media, and a better wealth status) [4][33]. All these 
factors are known to have influence on health seeking behavior including immunization.  
This study was prone to recall bias since respondents who did not show vaccination cards were 
asked to remember the vaccines. Causal inferences could not be drawn due to the cross-sectional nature 
of the study design. The use of already existing tools limited prevent us from including other variables 
that could explain vaccination uptake. 
 
CONCLUSIONS 
Interventions aimed at increasing further uptake of rotavirus and pneumococcal vaccines in 
Malawi should be designed interventions based on the factors addressed in this study. Specifically, the 
focus should be emphasized more on the maternal education so that they should have the health 
knowledge related to childhood vaccination. 
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Outcome variables     
 Pneumococcal conjugate vaccine (PCV13)     
  Incomplete coverage 521 11.16 0.58  
  Complete coveragea  4417 88.84 0.58  
 Monovalent rotavirus vaccine (RV1)     
  Incomplete coverage 427 9.04 0.53  
  Complete coverageb  4511 90.96 0.53  
Child characteristics      
 Sex of the child     
  Male 2449 49.07 0.90  
  Female 2489 50.93 0.90  
 Birth order     
  1 1439 30.20 0.94  
  2–3 1747 34.29 0.88  
  4–5 1100 22.14 0.73  
  ≥6 652 13.37 0.59  
Maternal/household Characteristics     
 Maternal age (years)     
  15–19 446 9.07 0.49  
  20–24 1538 31.79 0.96  
  25–29 1155 22.70 0.76  
  30–34 921 19.04 0.68  
  35–49 878 17.41 0.71  
 Maternal education levels     
  No education 535 11.40 0.60  
  Primary  3265 66.78 0.91  
  Secondary and above 1138 21.81 0.81  
 Maternal employment     
  Not working 1454 28.72 0.89  
  White collarc 576 11.17 0.59  
  Blue collard 2908 60.10 0.99  
 Wealth index     
  Poorest 1086 23.83 0.84  
  Poorer 1034 22.20 0.78  
  Middle 997 20.02 0.70  
  Richer 900 17.36 0.80  
  Richest 921 16.59 0.71  
 No of under-5-year children      
  ≤1 3097 62.68 0.90  
  2–3 1608 32.51 0.84  
  ≥4 233 4.80 0.41  
 Amount of media exposuree      
  0 2251 46.58 0.97  
  1  1589 32.66 0.86  
  2 756 14.81 0.70  
  3 342 5.95 0.46  
Health Service utilization     
 Place of delivery     
  Home and other 291 6.25 0.50  
  Hospital/institutionf 4647 93.75 0.50  
 Distance to health facility     
  No big problem 2306 43.31 1.31  
  Big problem 2632 56.69 1.31  
 Timing of 1st antenatal check     
  First trimester  1346 25.53 0.83  
  Second trimester 3307 67.87 0.89  
  Third trimester 285 6.60 0.46  
 Antenatal care visits     
  Inadequate visits (1-3)  2307 47.15 0.96  
  Adequate visits (≥4) 2631 52.85 0.96  
 Baby PNC check within 2 months     
  No  2658 54.52 1.06  
  Yes  2280 45.48 1.06  
 TTI during pregnancy     
  No  474 9.03 0.48  
  Yes  4464 90.97 0.48  
 Vaccination card     
  No card/no longer has card 942 19.04 0.67  
  Has card but not seen 386 7.34 0.47  
  Has card and seen 3610 73.61 0.78  
 Skilled assistance at delivery     
  No  355 8.02 0.54  
  Yesg  4583 91.98 0.54  
Community characteristics     
 Place of residence     
  Urban 829 13.99 0.60  
  Rural 4109 86.01 0.60  
 Geographical region     
  Northern 974 12.58 0.52  
  Central 1678 41.57 0.87  
  Southern 2286 45.85 0.88  
⸓Unweighted frequency; †weighted percentage; SE, standard error; TTI, tetanus toxoid injection; 
PNC, postnatal care; athree doses of the pneumococcal vaccine; btwo doses of the rotavirus vaccine; 
c(professional/technical/managerial, clerical, sales, services); d(agricultural - self-employed, 
agricultural - employee); e(frequency of reading newspaper or magazine, frequency of listening to 
radio, frequency of watching television); f(government hospital, government health center, 
government health post/outreach, other public sector, private hospital/ clinic, CHAM / MISSION 
hospital, CHAM / MISSION health center, BLM, other private medical sector); g(doctor/clinical 









Pneumococcal Conjugate Vaccine (PCV13)a 
  
Monovalent Human Rotavirus Vaccine (RV1)b 
   CrOR 95%(CI) p-value   AOR 95%(CI) p-value   CrOR 95%(CI) p-value   AOR 95%(CI) p-value  
Child characteristics            
 Sex of the child            
  Male  1.12 (0.89–1.49) 0.3230  — —  1.10 (0.86–1.42) 0.4584  1.11 (0.86–1.43) 0.4199 
  Female  1.00   — —  1.00 <.0001  1.00  
 Birth order            
  1 1.38 (0.96–0.88) 0.8778  1.88 (0.94–3.77) 0.1634  1.12 (0.75–1.67) 0.3029  1.18 (0.64–2.20) 0.8621 
  2–3 1.51 (1.05–2.18) 0.3791  1.51 (0.83–2.75) 0.8128  1.36 (0.93–1.99) 0.3572  1.28 (0.77–2.16) 0.6321 
  4–5 1.80 (1.21–2.67) 0.0188  1.62 (0.98–2.66) 0.4692  1.58 (1.04–2.45) 0.0407  1.44 (0.95–2.20) 0.2271 
  ≥6 1.00   1.00   1.00   1.00  
Maternal/household Characteristics            
 Maternal age (years)            
  15–19 0.95 (0.62–1.46) 0.3044  0.66 (0.31–1.43) 0.2281  0.71 (0.43–1.18) 0.0984  0.68 (0.33–1.44) 0.4592 
  20–24 1.04 (0.74–1.46) 0.5307  0.76 (0.41–1.43) 0.3918  0.89 (0.61–1.31) 0.5936  0.78 (0.43–1.37) 0.6968 
  25–29 1.28 (0.87–1.90) 0.2158  0.91 (0.52–1.61) 0.6995  1.07 (0.72–1.59) 0.2641  0.79 (0.49–1.25) 0.7860 
  30–34 1.30 (0.86–1.97) 0.2287  1.03 (0.62–1.72) 0.2968  1.10 (0.72–1.68) 0.2683  0.86 (0.56–1.32) 0.7468 
  35–49 1.00   1.00   1.00   1.00  
 Maternal education levels            
  No education 0.43 (0.29–0.64) <.0001  0.52 (0.33–0.85) 0.0020  0.36 (0.23–0.55) <.0001  0.40 (0.24–0.66) 0.0007 
  Primary  0.80 (0.58–1.12) 0.1210  0.90 (0.61–1.34) 0.1435  0.56 (0.40–0.78) 0.6155  0.60 (0.39–0.90) 0.6711 
  Secondary and above 1.00   1.00   1.00   1.00  
 Maternal employment            
  Not working 0.89 (0.70–1.15) 0.8306  0.89 (0.66–1.18) 0.8741  0.96 (0.71–1.30) 0.6276  0.99 (0.73–1.35) 0.6962 
  White collarc 0.86 (0.56–1.32) 0.6577  0.74 (0.45–1.23) 0.3457  1.08 (0.73–1.60) 0.6232  0.86 (0.55–1.34) 0.5108 
  Blue collard 1.00   1.00   1.00   1.00  
 Wealth index            
  Poorest 0.68 (0.47–0.96) 0.0014  1.05 (0.66–1.67) 0.3019  0.51 (0.33–0.77) 0.0011  0.78 (0.45–1.35) 0.1536 
  Poorer 1.20 (0.80–1.80) 0.0343  1.54 (0.96–2.45) 0.0447  0.81 (0.53–1.26) 0.3988  1.07 (0.63–1.81) 0.3135 
  Middle 0.84 (0.57–1.23) 0.3635  1.11 (0.70–1.76) 0.5726  0.60 (0.39–0.92) 0.0780  0.81 (0.49–1.34) 0.2041 
  Richer 1.00 (0.66–1.52) 0.4972  1.32 (0.82–2.11) 0.4591  0.87 (0.55–1.37) 0.2096  1.08 (0.65–1.79) 0.3207 
  Richest 1.00   1.00   1.00   1.00  
 Amount of media exposuree             
  1 0.50 (0.27–0.92) 0.0079  0.52 (0.25–1.07) 0.0808  0.72 (0.41–1.24) 0.0065  1.11 (0.56–2.20) 0.4809 
  2 0.56 (0.30–1.05) 0.1522  0.50 (0.25–1.01) 0.0357  0.91 (0.51–1.64) 0.6533  1.22 (0.61–2.43) 0.9815 
  3 0.69 (0.35–1.39) 0.7677  0.72 (0.34–1.50) 0.5894  1.36 (0.73–2.54) 0.0396  1.65 (0.82–3.30) 0.0772 
  4 1.00   1.00   1.00   1.00  
Health Service utilization            
 Place of delivery            
  Home and other 0.83 (0.54–1.26) 0.3763  0.86 (0.54–1.39) 0.5467  0.70 (0.45–1.08) 0.1033  0.70 (0.33–1.48) 0.3451 
  Hospital/institutionf 1.00   1.00   1.00   1.00  
 Distance to health facility            
  No big problem 0.99 (0.78–1.25) 0.9049  0.98 (0.75–1.27) 0.8522  1.14 (0.87–1.50) 0.3478  1.10 (0.84–1.46) 0.4899 
  Big problem 1.00   1.00   1.00   1.00  
 Baby PNC check within 2 months            
  No  0.62 (0.48–0.80) 0.0003  0.65 (0.49–0.86) 0.0030  0.63 (0.47–0.84) 0.0019  0.68 (0.49–0.92) 0.0140 
  Yes  1.00   1.00   1.00   1.00  
 TTI during pregnancy            
  No  1.17 (0.71–0.90) 0.5294  1.11 (0.64–1.93) 0.7094  0.89 (0.60–1.32) 0.5585  — — 
  Yes  1.00   1.00   1.00   — — 
 Vaccination card            
  No card/no longer has card 0.11 (0.08–0.15) <.0001  0.12 (0.09–0.15) <.0001  0.27 (0.21–0.36) <.0001  0.29 (0.49–0.92) <.0001 
  Has card but not seen 0.12 (0.08–0.17) <.0001  0.09 (0.06–0.13) <.0001  0.35 (0.24–0.51) 0.0280  0.33 (0.22–0.39) 0.0093 
  Has card and seen 1.00   1.00   1.00   1.00  
 Skilled assistance at delivery            
  No  0.99 (0.66–1.51) 0.9929  — —  0.78 (0.51–1.19) 0.2444  0.90 (0.44–1.85) 0.7712 
  Yesg  1.00   — —  1.00   1.00  
Community characteristics            
 Place of residence            
  Urban 0.72 (0.52–0.99) 0.0440  — —  1.21 (0.82–1.77) 0.3411  0.84 (0.53–1.33) 0.4565 
  Rural 1.00   — —  1.00   1.00  
 Geographical region            
  Northern 1.73 (1.23–2.45) 0.0010  1.82 (1.19–2.80) 0.0014  1.19 (0.84–1.69) 0.4356  0.99 (0.68–1.42) 0.8887 
  Central 0.98 (0.76–1.25) 0.0233  0.85 (0.64–1.12) 0.0031  1.09 (0.82–1.45) 0.9957  1.01 (0.75–1.34) 0.9095 
  Southern 1.00   1.00   1.00   1.00  
CrOR, crude odds ratio; AOR, adjusted odds ratio; TTI, tetanus toxoid injection; PNC, postnatal care;  athree doses of the pneumococcal vaccine; btwo doses of the 
rotavirus vaccine; c(professional/technical/managerial, clerical, sales, services); d(agricultural - self-employed, agricultural - employee); e(frequency of reading 
newspaper or magazine, frequency of listening to radio, frequency of watching television); f(government hospital, government health center, government health 
post/outreach, other public sector, private hospital/ clinic, CHAM / MISSION hospital, CHAM / MISSION health center, BLM, other private medical sector); 
g(doctor/clinical officer/medical assistant, nurse/midwife). The bold text indicate a statistically significant association at a p-value less than 0.05. 
 
 
